Impact of heparin-induced thrombocytopenia on acute coronary artery thrombosis in patients undergoing PCI

Takuma Maeda; Teruo Noguchi; Shin Saito; Rei Yoshioka; Eishun Horibe; Sunao Miyanaga; Shu Seguchi; Yoshiaki Kanaumi; Takeshi Kawai; Hitoshi Okazaki; Shigeki Miyata

doi:10.1160/TH13-11-0936

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 2014; 112(03): 624-626
DOI: 10.1160/TH13-11-0936

Letters to the Editor

Schattauer GmbH

Impact of heparin-induced thrombocytopenia on acute coronary artery thrombosis in patients undergoing PCI

Autor*innen

Takuma Maeda

¹Division of Transfusion Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan
Teruo Noguchi

²Department of Cardiology, National Cerebral and Cardiovascular Center, Osaka, Japan
Shin Saito

³Department of Cardiology, Hirosaki University School of Medicine and Hospital, Aomori, Japan
Rei Yoshioka

⁴Department of Cardiology, Yanagawa Hospital, Fukuoka, Japan
Eishun Horibe

⁵Department of Cardiology, Japanese Red Cross Takayama Hospital, Gifu, Japan
Sunao Miyanaga

⁶Department of Cardiology, Sendai Medical Association Hospital, Kagoshima, Japan
Shu Seguchi

¹Division of Transfusion Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan
Yoshiaki Kanaumi

¹Division of Transfusion Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan
Takeshi Kawai

¹Division of Transfusion Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan
Hitoshi Okazaki

⁷Department of Transfusion Medicine, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo, Tokyo, Japan
Shigeki Miyata

¹Division of Transfusion Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan

Abstract

Volltext

Referenzen

References
1 McEntegart MB, Kirtane AJ, Cristea E. et al. Intra-procedural thrombotic events during percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes are associated with adverse outcomes: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. J Am Coll Cardiol 2012; 59: 1745-1751.
2 Brieger DB, Mak KH, Kottke-Marchant K. et al. Heparin-induced thrombocytopenia. J Am Coll Cardiol 1998; 31: 1449-1459.
3 Lee DH, Warkentin TE, Denomme GA. et al. A diagnostic test for heparin-induced thrombocytopenia: detection of platelet microparticles using flow cytometry. Br J Haematol 1996; 95: 724-731.
4 Hughes M, Hayward CP, Warkentin TE. et al. Morphological analysis of microparticle generation in heparin-induced thrombocytopenia. Blood 2000; 96: 188-194.
5 Warkentin TE, Kelton JG. Delayed-onset heparin-induced thrombocytopenia and thrombosis. Ann Intern Med 2001; 135: 502-506.
6 Fefer P, Daoulah A, Strauss BH. et al. Visible angiographic complications predict short and long-term outcomes in patients with post-procedural creatine-phosphokinase elevation. Catheter Cardiovasc Interv 2010; 76: 960-966.
7 Williams RT, Damaraju LV, Mascelli MA. et al. Anti-platelet factor 4/heparin antibodies: an independent predictor of 30-day myocardial infarction after acute coronary ischemic syndromes. Circulation 2003; 107: 2307-2312.
8 Foo SY, Everett BM, Yeh RW. et al. Prevalence of heparin-induced thrombocytopenia in patients undergoing cardiac catheterization. Am Heart J 2006; 152: 290e1-7.
9 Warkentin TE, Sheppard JA, Moore JC. et al. Studies of the immune response in heparin-induced thrombocytopenia. Blood 2009; 113: 4963-4969.
10 Warkentin TE, Kelton JG. Temporal aspects of heparin-induced thrombocytopenia. N Engl J Med 2001; 344: 1286-1292.
11 Warkentin TE, Cuker A. Differential diagnosis of heparin-induced thrombocytopenia and scoring system. In Warkentin TE, Greinacher A. eds Heparin-induced thrombocytopenia. 5th ed. CRC press; 2013. p 77-109.
12 Kornowski R, Mehran R, Dangas G. et al. Prognostic impact of staged versus "one-time" multi-vessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial. J Am Coll Cardiol 2011; 58: 704-711.
13 Vlaar PJ, Mahmoud KD, Holmes Jr. DR. et al. Culprit vessel only versus multivessel and staged percutaneous coronary intervention for multivessel disease in patients presenting with ST-segment elevation myocardial infarction: a pairwise and network meta-analysis. J Am Coll Cardiol 2011; 58: 692-703.
14 Mahaffey KW, Lewis BE, Wildermann NM. et al. The anticoagulant therapy with bivalirudin to assist in the performance of percutaneous coronary intervention in patients with heparin-induced thrombocytopenia (ATBAT) study: main results. J Invasive Cardiol 2003; 15: 611-616.
15 Lewis BE, Matthai Jr. WH, Cohen M. et al. Argatroban anticoagulation during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia. Catheter Cardiovasc Interv 2002; 57: 177-184.

Zusatzmaterial

Zusatzmaterial (PDF) (opens in new window)